ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,629
-77.7%
35,624
-79.8%
0.00%
-81.0%
Q1 2023$16,252
-95.7%
176,652
-95.7%
0.02%
-96.0%
Q4 2022$374,409
-99.7%
4,127,082
+153.4%
0.52%
+186.3%
Q3 2022$123,800,000
-6.7%
1,628,727
+3.8%
0.18%
-2.7%
Q2 2022$132,644,000
-24.1%
1,569,193
-21.2%
0.19%
-13.8%
Q1 2022$174,847,000
+103.6%
1,992,558
+103.0%
0.22%
+107.6%
Q4 2021$85,874,000
+55.0%
981,752
+44.9%
0.10%
+52.2%
Q3 2021$55,395,000
+80.3%
677,369
+101.2%
0.07%
+81.6%
Q2 2021$30,721,000
+78.2%
336,700
+67.0%
0.04%
+65.2%
Q1 2021$17,237,000
+3688.4%
201,654
+4088.0%
0.02%
+2200.0%
Q4 2020$455,000
-99.7%
4,815
-99.7%
0.00%
-99.6%
Q3 2020$148,216,000
-44.7%
1,704,418
-44.5%
0.24%
-52.3%
Q2 2020$267,986,000
-33.6%
3,068,310
-37.3%
0.49%
-56.6%
Q1 2020$403,513,000
+5.0%
4,894,029
+20.6%
1.14%
+27.2%
Q4 2019$384,284,000
+36.8%
4,058,336
+25.5%
0.89%
+36.3%
Q3 2019$280,985,000
+1.8%
3,233,430
+7.0%
0.66%
+6.5%
Q2 2019$276,025,000
-38.7%
3,022,941
-35.4%
0.62%
-42.2%
Q1 2019$450,051,000
+60.6%
4,681,206
+43.3%
1.06%
+45.0%
Q4 2018$280,275,000
+4.7%
3,266,230
+5.2%
0.73%
+21.3%
Q3 2018$267,626,000
+413.7%
3,106,154
+350.4%
0.60%
+372.7%
Q2 2018$52,100,000
+128.3%
689,700
+144.4%
0.13%
+146.2%
Q1 2018$22,818,000
+70.5%
282,225
+77.1%
0.05%
+62.5%
Q4 2017$13,383,000
+575.6%
159,400
+590.7%
0.03%
+540.0%
Q3 2017$1,981,000
-98.0%
23,079
-98.3%
0.01%
-98.6%
Q1 2017$98,603,0001,327,6290.36%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders